Systemic effects of chronic obstructive pulmonary disease

被引:586
|
作者
Agustí, AGN
Noguera, A
Sauleda, J
Sala, E
Pons, J
Busquets, X
机构
[1] Hosp Univ Son Dureta, Serv Pneumol, Palma de Mallorca 07014, Spain
[2] Hosp Univ Son Dureta, Anal Clin, Palma de Mallorca 07014, Spain
[3] Hosp Univ Son Dureta, Univ Invest, Palma de Mallorca 07014, Spain
关键词
chronic bronchitis; chronic obstructive pulmonary disease; emphysema; inflammation;
D O I
10.1183/09031936.03.00405703
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Chronic obstructive pulmonary disease (COPD) is characterised by an inappropriate/excessive inflammatory response of the lungs to respiratory pollutants, mainly tobacco smoking. Recently, besides the typical pulmonary pathology of COPD (i.e. chronic bronchitis and emphysema), several effects occurring outside the lungs have been described, the so called systemic effects of COPD. These effects are clinically relevant because they modify and can help in the classification and management of the disease. The present review discusses the following systemic effects of chronic obstructive pulmonary disease: 1) systemic inflammation; 2) nutritional abnormalities and weight loss; 3) skeletal muscle dysfunction; and 4) other potential systemic effects. For each of these, the potential mechanisms and clinical implications are discussed and areas requiring further research are highlighted.
引用
收藏
页码:347 / 360
页数:14
相关论文
共 50 条
  • [11] Systemic inflammation in chronic obstructive pulmonary disease
    Oudijk, EJD
    Lammers, JWJ
    Koenderman, L
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 : 5S - 13S
  • [12] Systemic and Pulmonary Vascular Remodelling in Chronic Obstructive Pulmonary Disease
    Munoz-Esquerre, Mariana
    Lopez-Sanchez, Marta
    Escobar, Ignacio
    Huertas, Daniel
    Penin, Rosa
    Molina-Molina, Maria
    Manresa, Frederic
    Dorca, Jordi
    Santos, Salud
    PLOS ONE, 2016, 11 (04):
  • [13] Pharmacokinetics and systemic effects of inhaled fluticasone propionate in chronic obstructive pulmonary disease
    Singh, SD
    Whale, C
    Houghton, N
    Daley-Yates, P
    Kirby, SM
    Woodcock, AA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 55 (04) : 375 - 381
  • [14] Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease
    Barbaro, M. P. Foschino
    Carpagnano, G. E.
    Spanevello, A.
    Cagnazzo, M. G.
    Barnes, P. J.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2007, 20 (04) : 753 - 763
  • [15] Chronic obstructive pulmonary disease as a systemic disease: an epidemiological perspective
    Andreassen, H
    Vestbo, J
    EUROPEAN RESPIRATORY JOURNAL, 2003, 22 : 2S - 4S
  • [16] Other systemic manifestations of chronic obstructive pulmonary disease
    Stone, Andrew C.
    Nici, Linda
    CLINICS IN CHEST MEDICINE, 2007, 28 (03) : 553 - +
  • [17] Systemic elastin degradation in chronic obstructive pulmonary disease
    Maclay, John D.
    McAllister, David A.
    Rabinovich, Roberto
    Haq, Imran
    Maxwell, Scott
    Hartland, Stephen
    Connell, Martin
    Murchison, John T.
    van Beek, Edwin J. R.
    Gray, Robert D.
    Mills, Nicholas L.
    MacNee, William
    THORAX, 2012, 67 (07) : 606 - 612
  • [18] Systemic vascular function in chronic obstructive pulmonary disease
    Del Pozo, Roberto
    Garcia, Jessica
    Chamorro, Nuria
    Coronel, Maria
    Coll, Nuria
    Blanco, Isabel
    Peinado, Victor
    Albert Barbera, Joan
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [19] Effects of pulmonary rehabilitation on systemic inflammation in chronic obstructive pulmonary disease: a meta-analysis
    Yue, Xiaotian Alex
    Sheng, Yilan
    Li, Jianhua
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2024, 13 (01) : 1 - 11
  • [20] Systemic inflammation in patients with chronic obstructive pulmonary disease
    Sanina, Nataliia
    Pertseva, Tetyana
    Panina, Svitlana
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42